{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:53:23Z","timestamp":1788951203626,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.xphs.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T10:50:19Z","timestamp":1585565419000},"page":"2321-2335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy"],"prefix":"10.1016","volume":"109","author":[{"given":"Ahmad H.","family":"Alammari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif M.","family":"Shoieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid H.","family":"Maayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1253\/circj.CJ-16-0062","article-title":"From left ventricular hypertrophy to dysfunction and failure","volume":"80","author":"Lazzeroni","year":"2016","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.xphs.2020.03.016_bib2","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.xphs.2020.03.016_bib3","year":"2017"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/ars.1999.1.2-167","article-title":"Arachidonic acid metabolites mediate angiotensin II-induced NADH\/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells","volume":"1","author":"Zafari","year":"1999","journal-title":"Antioxidants Redox Signal"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2016.1257021","article-title":"Microsomal cytochrome P450 as a target for drug discovery and repurposing","volume":"49","author":"El-Sherbeni","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"8","key":"10.1016\/j.xphs.2020.03.016_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/dmd.32.8.840","article-title":"Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1","volume":"32","author":"Choudhary","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2020.03.016_bib7","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.bjp.0703465","article-title":"Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat","volume":"130","author":"Thum","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.vascn.2007.06.001","article-title":"H9c2 cell line is a valuable in\u00a0vitro model to study the drug metabolizing enzymes in the heart","volume":"56","author":"Zordoky","year":"2007","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"key":"10.1016\/j.xphs.2020.03.016_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vascn.2014.11.005","article-title":"Human fetal ventricular cardiomyocyte, RL-14 cell line, is a promising model to study drug metabolizing enzymes and their associated arachidonic acid metabolites","volume":"71","author":"Maayah","year":"2015","journal-title":"J\u00a0Pharmacol Toxicol Methods"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P\u00a0-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00204-014-1419-z","article-title":"5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-\u03baB-dependent mechanism","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00204-015-1620-8","article-title":"The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy","volume":"90","author":"Maayah","year":"2016","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003088-199733010-00005","article-title":"Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses","volume":"33","author":"Debruyne","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2020.03.016_bib15","series-title":"Guidance for Industry Drug interaction studies\u2014study design, data analysis, implications for dosing, and labeling recommendation.","year":"2013"},{"issue":"4","key":"10.1016\/j.xphs.2020.03.016_bib16","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/acs.molpharmaceut.5b00873","article-title":"Repurposing resveratrol and fluconazole to modulate human cytochrome P450-mediated arachidonic acid metabolism","volume":"13","author":"El-Sherbeni","year":"2016","journal-title":"Mol Pharm"},{"issue":"4-5","key":"10.1016\/j.xphs.2020.03.016_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10565-015-9308-7","article-title":"Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-\u03baB","volume":"31","author":"Maayah","year":"2015","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.xphs.2020.03.016_bib18","series-title":"Immortalization of human post-mitotic cells.","author":"Davidson","year":"2007"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","article-title":"Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction","volume":"69","author":"Liu","year":"1997","journal-title":"J\u00a0Neurochem"},{"issue":"1-2","key":"10.1016\/j.xphs.2020.03.016_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11010-017-2943-y","article-title":"The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol","volume":"429","author":"Maayah","year":"2017","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/abio.1993.1239","article-title":"Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader","volume":"211","author":"Kennedy","year":"1993","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2020.03.016_bib23","doi-asserted-by":"crossref","first-page":"F408","DOI":"10.1152\/ajprenal.00542.2011","article-title":"Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats","volume":"302","author":"Jennings","year":"2012","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/dmd.118.084657","article-title":"Identification of 19-( S\/R )hydroxyeicosatetraenoic acid as the first endogenous noncompetitive inhibitor of cytochrome P450 1B1 with enantioselective activity","volume":"47","author":"Shoieb","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"5-6","key":"10.1016\/j.xphs.2020.03.016_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","article-title":"Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line","volume":"58","author":"Tse","year":"2013","journal-title":"Vasc Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2020.03.016_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/dmd.104.002253","article-title":"Tert-butylhydroquinone is a novel aryl hydrocarbon receptor ligand","volume":"33","author":"Gharavi","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.xphs.2020.03.016_bib28","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.xphs.2020.03.016_bib29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI13210","article-title":"Arachidonic acid as a bioactive molecule","volume":"107","author":"Brash","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-2275(20)37440-X","article-title":"High polyunsaturated fatty acid, thromboxane A2, and alpha- fetoprotein concentrations at the human feto-maternal interface","volume":"38","author":"Benassayag","year":"1997","journal-title":"J\u00a0Lipid Res"},{"issue":"12","key":"10.1016\/j.xphs.2020.03.016_bib31","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1073\/pnas.72.12.5130","article-title":"Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis","volume":"72","author":"Hammarstr\u00f6m","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2020.03.016_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jchromb.2013.08.008","article-title":"UHPLC-MS\/MS analysis of arachidonic acid and 10 of its major cytochrome P450 metabolites as free acids in rat livers: effects of hepatic ischemia","volume":"964","author":"Edpuganti","year":"2014","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.103.059626","article-title":"Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes","volume":"308","author":"Xu","year":"2004","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"6","key":"10.1016\/j.xphs.2020.03.016_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2133\/dmpk.20.478","article-title":"Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs","volume":"20","author":"Imaoka","year":"2005","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.xphs.2020.03.016_bib35","article-title":"Measurement of soluble epoxide hydrolase (sEH) activity","volume":"Vol. Chapter 4","author":"Morisseau","year":"2007"},{"issue":"6","key":"10.1016\/j.xphs.2020.03.016_bib36","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/HYPERTENSIONAHA.112.202606","article-title":"Cytochrome P450 1B1 gene disruption minimizes deoxycorticosterone acetate-salt-induced hypertension and associated cardiac dysfunction and renal damage in mice","volume":"60","author":"Jennings","year":"2012","journal-title":"Hypertension (Dallas)"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.111.183301","article-title":"Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice","volume":"59","author":"Jennings","year":"2012","journal-title":"Hypertension (Dallas)"},{"issue":"11","key":"10.1016\/j.xphs.2020.03.016_bib38","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2020.03.016_bib39","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fj.02-0138com","article-title":"Testosterone, cytochrome P450, and cardiac hypertrophy","volume":"16","author":"Thum","year":"2002","journal-title":"Faseb J"},{"issue":"4","key":"10.1016\/j.xphs.2020.03.016_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/HYPERTENSIONAHA.110.154518","article-title":"Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology","volume":"56","author":"Jennings","year":"2010","journal-title":"Hypertension (Dallas)"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/FJC.0000000000000494","article-title":"Inhibition of mid-chain HETEs protects against angiotensin II\u2013induced cardiac hypertrophy","volume":"70","author":"Elkhatali","year":"2017","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.xphs.2020.03.016_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138920008783571792","article-title":"Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure","volume":"9","author":"Zordoky","year":"2008","journal-title":"Curr Drug Metabol"},{"issue":"8","key":"10.1016\/j.xphs.2020.03.016_bib44","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/dmd.32.8.840","article-title":"Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1","volume":"32","author":"Choudhary","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.xphs.2020.03.016_bib45","first-page":"617","article-title":"Oxidation of xenobiotics by recombinant human cytochrome P450 1B1","volume":"25","author":"Shimada","year":"1997","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/dmd.118.084657","article-title":"Identification of 19-( S\/R )hydroxyeicosatetraenoic acid as the first endogenous noncompetitive inhibitor of cytochrome P450 1B1 with enantioselective activity","volume":"47","author":"Shoieb","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.pharmtox.41.1.297","article-title":"Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1","volume":"41","author":"Murray","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(24)12186-4","article-title":"Regulation of cytochrome P-450 (CYP) 1B1 in mouse Hepa-1 variant cell lines: a possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression","volume":"55","author":"Eltom","year":"1999","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/toxsci\/kfm012","article-title":"Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines","volume":"97","author":"Korashy","year":"2007","journal-title":"Toxicol Sci"},{"issue":"11","key":"10.1016\/j.xphs.2020.03.016_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1191\/0960327104ht479oa","article-title":"Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in\u00a0vivo study","volume":"23","author":"Somchit","year":"2004","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/01480540600651535","article-title":"Involvement of phenobarbital and SKF 525A in the hepatotoxicity of antifungal drugs itraconazole and fluconazole in rats","volume":"29","author":"Somchit","year":"2006","journal-title":"Drug Chem Toxicol"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007013808797","article-title":"Comparative efficacy of fluconazole and amphotericin B in the parenteral treatment of experimental paracoccidioidomycosis in the rat","volume":"146","author":"Martinez","year":"1999","journal-title":"Mycopathologia"},{"issue":"6","key":"10.1016\/j.xphs.2020.03.016_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2133\/dmpk.20.485","article-title":"Pharmacokinetics of fluconazole and fosfluconazole after intraperitoneal administration to peritoneal dialysis rats","volume":"20","author":"Aoyama","year":"2005","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2020.03.016_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/FJC.0000000000000036","article-title":"Fenofibrate modulates cytochrome P450 and arachidonic acid metabolism in the heart and protects against isoproterenol-induced cardiac hypertrophy","volume":"63","author":"Althurwi","year":"2014","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2020.03.016_bib55","first-page":"294","article-title":"20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways","volume":"57","author":"Bao","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2016.1257021","article-title":"Microsomal cytochrome P450 as a target for drug discovery and repurposing","volume":"49","author":"El-Sherbeni","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.xphs.2020.03.016_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/FJC.0000000000000494","article-title":"Inhibition of mid-chain HETEs protects against angiotensin II-induced cardiac hypertrophy","volume":"70","author":"Elkhatali","year":"2017","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2020.03.016_bib58","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1124\/dmd.118.082073","article-title":"S- enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy","volume":"46","author":"Shoieb","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.xphs.2020.03.016_bib59","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","article-title":"Molecular regulation of cardiac hypertrophy","volume":"40","author":"Barry","year":"2008","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920301751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354920301751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:30:29Z","timestamp":1758360629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354920301751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0022354920301751"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2020.03.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}